Abstract
The receptor for advanced glycation endproducts (RAGE) has been shown to play an important role in aging, neurodegeneration, diabetes, and inflammation. RAGE is a transmembrane receptor of the immunoglobuline superfamily, which recognizes a variety of ligands such as AGEs (advanced glycation endproducts), members of the S100/calgranulin family of proinflammatory mediators, β-sheet-fibrills, HMGB1 (amphoterin) and the 2-integrin Mac-1. RAGE/ligand interactions induce oxidative stress and lead to an up-regulation of pro-inflammatory pathways involving the proinflammatory transcription factor NF-κB, increased expression of cytokines, chemokines, and adhesion molecules. These effects markedly propagate cellular dysfunction and cause perturbation in a diverse group of diseases, such as agerelated neurodegenerative disorders, atherosclerosis, diabetic vascular complications, tumors, and chronic inflammatory disease. In addition, RAGE may also interfere with differentiation processes, which are required during organ development. In this article, we have reviewed recent advances on RAGE and RAGE/ligand function in cell adhesion and inflammation based on findings from cell cultures, animal models, and human diseases. The potential for targeting the RAGE/ligand pathway as therapeutic strategy will be discussed.
Keywords: RAGE expression, proinflammatory, chemokines, cytokines, chronic kidney disease (CKD)
Current Pediatric Reviews
Title: RAGE Signaling in Cell Adhesion and Inflammation
Volume: 3 Issue: 1
Author(s): Barbel Lange-Sperandio, Markus Sperandio, Peter Nawroth and Angelika Bierhaus
Affiliation:
Keywords: RAGE expression, proinflammatory, chemokines, cytokines, chronic kidney disease (CKD)
Abstract: The receptor for advanced glycation endproducts (RAGE) has been shown to play an important role in aging, neurodegeneration, diabetes, and inflammation. RAGE is a transmembrane receptor of the immunoglobuline superfamily, which recognizes a variety of ligands such as AGEs (advanced glycation endproducts), members of the S100/calgranulin family of proinflammatory mediators, β-sheet-fibrills, HMGB1 (amphoterin) and the 2-integrin Mac-1. RAGE/ligand interactions induce oxidative stress and lead to an up-regulation of pro-inflammatory pathways involving the proinflammatory transcription factor NF-κB, increased expression of cytokines, chemokines, and adhesion molecules. These effects markedly propagate cellular dysfunction and cause perturbation in a diverse group of diseases, such as agerelated neurodegenerative disorders, atherosclerosis, diabetic vascular complications, tumors, and chronic inflammatory disease. In addition, RAGE may also interfere with differentiation processes, which are required during organ development. In this article, we have reviewed recent advances on RAGE and RAGE/ligand function in cell adhesion and inflammation based on findings from cell cultures, animal models, and human diseases. The potential for targeting the RAGE/ligand pathway as therapeutic strategy will be discussed.
Export Options
About this article
Cite this article as:
Lange-Sperandio Barbel, Sperandio Markus, Nawroth Peter and Bierhaus Angelika, RAGE Signaling in Cell Adhesion and Inflammation, Current Pediatric Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/1573396310703010001
DOI https://dx.doi.org/10.2174/1573396310703010001 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Geniposide Attenuates Oligomeric Aβ<sub>1-42</sub>-Induced Inflammatory Response by Targeting RAGE-Dependent Signaling in BV2 Cells
Current Alzheimer Research Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity
Current Alzheimer Research New Perspectives in the Pharmacological Potential of Naringin in Medicine
Current Medicinal Chemistry Editorial (Thematic Issue: NeuroAIDS: Past, Present and Future)
Current HIV Research Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Discovery of Novel Compounds Targeting DJ-1 as Neuroprotectants for Parkinson’s Disease by Virtual Screening and In Silico Method
Current Computer-Aided Drug Design The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s Disease
Current Alzheimer Research New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection
Current Pharmaceutical Design Search and Rescue: Identification of Cannabinoid Actions Relevant for Neuronal Survival and Protection
Current Neuropharmacology Non-Antidepressant Pharmacological Treatment of Obsessive Compulsive Disorder: A Comprehensive Review
Current Clinical Pharmacology Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design
Current Medicinal Chemistry Expression and Function of Cytochrome P450 in Brain Drug Metabolism
Current Drug Metabolism The Professional Phagocyte Dictyostelium discoideum as a Model Host for Bacterial Pathogens
Current Drug Targets Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry Basis for the Application of Analytical Models of the Bloch NMR Flow Equations for Functional Magnetic Resonance Imaging (fMRI): A Review
Recent Patents on Medical Imaging Toxins Targeting Voltage-Activated Ca<sup>2+</sup> Channels and their Potential Biomedical Applications
Current Topics in Medicinal Chemistry G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer’s Disease: A Systematic Literature Review
Current Medicinal Chemistry Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry